During the past decade, Medical ICU conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical ICU"
#1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator and "University Paris 7 - Denis Diderot" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Medical ICU
According to Clinical.Site data, the most researched conditions in "Medical ICU" are
"Acute Respiratory Failure" (1 trials), "Critically Ill Patients" (1 trials), "Hematologic Neoplasms" (1 trials), "Immunocompromised Patient" (1 trials) and "Immunosuppressive Agents" (1 trials). Many other conditions were trialed in "Medical ICU" in a lesser frequency.
Clinical Trials Intervention Types at Medical ICU
Most popular intervention types in "Medical ICU" are "Behavioral" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "End of ICU stay conference" (1 trials), "HFNO" (1 trials), "Methylprednisolone" (1 trials), "Placebo" (1 trials) and "standard oxygen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medical ICU
The vast majority of trials in "Medical ICU" are
3 trials for "All" genders.
Clinical Trials Status at Medical ICU
Currently, there are NaN active trials in "Medical ICU".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Medical ICU,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medical ICU, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".